Press Releases

NEW YORK, Nov. 8, 2019 /PRNewswire/ -- Today, New York Edge, the largest provider of afterschool programs in the metropolitan region, announced a partnership with Fidelis Care, a leading health plan providing quality, affordable coverage for more than 1.7 million New Yorkers. Through the partnership, a variety of health and wellness programs will be provided to New

SANTA CLARA, Calif., Nov. 8, 2019 /PRNewswire/ -- eHealth, Inc. (NASDAQ: EHTH), a leading private online health insurance exchange, announced today that its senior management will deliver presentations at the following upcoming investor conferences: 28th Annual Credit Suisse Healthcare Conference, on Tuesda

AUSTIN, Texas, Nov. 8, 2019 /PRNewswire/ -- HealthGrowth Capital, LLC, a leading lender and strategic consultant to independent pharmacies, is pleased to announce the appointment of Todd C. Ebert to the Company's Board of Advisors, effective immediately."We are delighted to welcome Todd Ebert to ou

The Partnership Seeks to Develop Cannabis-Based Products for the Treatment of Human Diseases, Beginning with Colon Cancer CORONA, CA, Nov. 8, 2019 /PRNewswire/ - Ikänik Farms, Inc. (the "Company") is pleased to announce that Ikänik International, Inc. ("Ikänik International"), represented by its medical division in

COLUMBUS, Ohio, Nov. 8, 2019 /PRNewswire/ -- Big Lots announced today the conclusion of the company's eighth point-of-sale fundraising campaign that benefits Nationwide Children's Hospital. The "Give Big for Kids" campaign raised a total of $3.05 million in more than 1,400 stores that employ over 35,000 Big Lots associates. Over the pas

SEATTLE and LUND, Sweden, Nov. 8, 2019 /PRNewswire/ -- Aptevo Therapeutics Inc. (Nasdaq: APVO), a biotechnology company focused on developing novel immuno-oncology and hematology therapeutics and Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immuno

BRUSSELS, Nov. 8, 2019 /PRNewswire/ -- UCB, a global biopharmaceutical company, today announced important new rheumatology data being presented on CIMZIA® (certolizumab pegol) and investigational molecules bimekizumab and dapirolizumab pegol at the 2019 American College of Rheumatology and the Association of Rheumatology Professionals (ACR/ARP) Annual Me

SAN FRANCISCO, Nov. 8, 2019 /PRNewswire/ -- Lexent Bio, Inc., a precision oncology company developing novel liquid biopsy systems, today announced a non-exclusive partnership with Illumina, Inc. (NASDAQ: ILMN) to develop an in-vitro diagnostic (IVD) kit for Lexent's future portfolio of next-generation sequencing (NGS)-based cancer diagnostics.The IVD kit under dev

LAINATE, Italy, Nov. 8, 2019 /PRNewswire/ -- Cassiopea SpA (SIX: SKIN), a specialty pharmaceutical company developing and commercializing prescription drugs with novel mechanisms of action (MOA) to address long-standing and essential dermatological conditions, announced today the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Applicatio

PHOENIX, Nov. 8, 2019 /PRNewswire/ -- Harvest Health & Recreation, Inc. (CSE: HARV, OTCQX: HRVSF) ("Harvest"), a vertically integrated cannab